10 employees
Biscayne Neurotherapeutics is a clinical-stage biotechnology company which develops novel drugs for central nervous system disorders.
2017
$3M
from 1 investors over 1 rounds
Biscayne Neurotherapeutics Inc raised $3M on January 27, 2017
Investors: Quark Venture